Question

In: Statistics and Probability

A randomized clinical trial was designed to test the efficacy of a new serotonin-reuptake inhibitor (anxiety...

A randomized clinical trial was designed to test the efficacy of a new serotonin-reuptake inhibitor (anxiety reducing drug – ARD) to treat the symptoms of anxiety compared to a more traditional approach of behavioral therapy. The trial randomized 1,200 men and women with untreated anxiety symptoms in a 1:1 ratio to either 1) treatment with ARD, and 2) weekly behavioral therapy sessions. The primary endpoint was resolution of anxiety based on results from a validated anxiety assessment instrument. At six months of follow-up it was found that 200 persons in the ARD group and 50 in the behavioral therapy group met the primary endpoint.

-Create a 2X2 table below and calculate the relative risk of anxiety symptoms for persons in the behavioral therapy group compared to those taking ARD. State your results in a sentence.

- Calculate the efficacy (as risk reduction) of ARD compared to behavioral therapy. State your results in a sentence.

-How many patients with untreated anxiety would you need to treated with ARD

(instead of behavioral therapy) to resolve the symptoms of anxiety over 6 months?

-In performing the analysis, it was discovered that men responded better to ARD than women, but they had similar responses to behavioral therapy. Also, the majority of subjects in the study were women. How might this affect your results? Can you suggest a study design that might improve the validity of your findings?

Solutions

Expert Solution

The total number of population here is 1200.

No. of people in the ARD group having anxiety = 200

No. of people in the Behavioural therapy group having anxiety = 50.

Now we will construct the 2 X 2 table : (The table below is always constructed in this way with the same row and column headings because if these headings change then the complete formula of relative risk will change)

DISEASE ( HAVING ANXIETY) NO DISEASE (NOT HAVING ANXIETY) TOTAL
ARD GROUP (a) 200 (b) 475 675
BEHAVIOURAL THERAPY (c) 50 (d) 475 525
TOTAL 250 950

Relative Risk = = = 3.11

Since the relative risk is greater than 1 we have that the people in ARD group have more risk of having anxiety than the ones in the Behavioural therapy group.

If the risk was equal to one then both the groups would have same amount of risk, and if the risk was less than 1 then the ARD group would have less risk than the behavioural therapy group.

(b) Basically the relative risk reduction means the decrease of probability is the recognitional risk of one group of people to another. Now the formula for the relative risk reduction is 1 - relative risk = -2.11. Since the relative risk reduction is less than 1 , it signifies that the risk of developing anxiety is reduced by this percentage.

(c) From the table we can see that 475 no. of people should be treated with ARD group rather than the behavioural therapy.


Related Solutions

Suppose a clinical trial is conducted to test the efficacy of a drug ! for treating...
Suppose a clinical trial is conducted to test the efficacy of a drug ! for treating gonorrhea in females. 100 female patients with gonorrhea are given this drug and are seen 2 weeks later, at which time 10 of the 100 patients still have gonorrhea. A.) What is the best point estimate for p, the probability of a failure with the drug A? 5% 10% 15% 20% B) What is the Standard error of the point estimate? 10% 9% 5%...
A clinical trial is run to look at the efficacy of a new blood pressure drug....
A clinical trial is run to look at the efficacy of a new blood pressure drug. Patients with a diagnosis of hypertension (high blood pressure) are recruited to participate in the trial and randomized to receive either the new drug or placebo. Participants take the assigned drug for 12 weeks and their blood pressure status is recorded. At the end of the trial, participants are classified as still having hypertension or not. The data are shown here: Group Number with...
2. A clinical trial is conducted to evaluate the efficacy of a new drug for prevention...
2. A clinical trial is conducted to evaluate the efficacy of a new drug for prevention of hypertension in patients with pre-hypertension (defined as systolic blood pressure between 120–139 mmHg or diastolic blood pressure between 80–89 mmHg). A total of 20 patients are randomized to receive the new drug or a currently available drug for treatment of high blood pressure. Participants are followed for up to 12 months, and time to progression to hypertension is measured. The experiences of participants...
A clinical trial is being conducted in order to determine the efficacy of a new drug...
A clinical trial is being conducted in order to determine the efficacy of a new drug that will be used to treat type II diabetes. The efficacy of the medication will be determined by the blood glucose readings obtained from the patients. If the researcher wants a margin of error less than or equal to 5 mg/dL and the standard deviation for blood glucose readings among type II diabetics was previous documented as 15 mg/dL, how many patients should be...
A clinical trial is run to evaluate the efficacy of a new medication to relieve pain...
A clinical trial is run to evaluate the efficacy of a new medication to relieve pain in patients undergoing total knee replacement surgery. In the trial, patients are randomly assigned to receive either the new medication or the standard medication. After receiving the assigned medication, patients are asked to report their pain on a scale of 0-100 with higher scores indicative of more pain. Data on the primary outcome are shown below. Sample Size Mean Pain Score Standard Deviation of...
A clinical trial is conducted to test a new medication designed to lower systolic blood pressure...
A clinical trial is conducted to test a new medication designed to lower systolic blood pressure (SBP). Participants are randomly assigned to receive the new medication or a placebo. The outcome is clinically significant SBP reduction after 30 days. The data are shown below. Compute the totals. Significant Reduction in SBP No Significant Reduction in SBP Total New Medication 44 76 Placebo 21 99 Total Compute the proportion of participants who experienced a significant reduction in SBP, given they received...
4S coronary mortality. The Scandinavian simvastatin survival study (4S) was a randomized clinical trial designed to...
4S coronary mortality. The Scandinavian simvastatin survival study (4S) was a randomized clinical trial designed to evaluate the effects of the cholesterol-lowering agent simvastatin in patients with coronary heart disease. Over 5.4 years of follow-up, the treatment group consisting of 2221 individuals experienced 111 fatal heart attacks. The placebo group of 2223 individuals experienced 189 such events. Calculate the risks in the groups and test the difference for significance. In relative terms, how much did simvastatin lower heart attack mortality?
You are designing a randomized clinical trial of a new anti-hypertensive medication. The goal is to...
You are designing a randomized clinical trial of a new anti-hypertensive medication. The goal is to lower the incidence of stroke, but a surrogate endpoint will be used instead of stroke as the primary endpoint of the trial. (1) Give an example of a surrogate endpoint that makes sense for the context of this clinical trial. (2) In the context of this trial, give a rationale for why an investigator might decide to use a surrogate endpoint.
A clinical trial was conducted using a new method designed to increase the probability of conceiving...
A clinical trial was conducted using a new method designed to increase the probability of conceiving a girl. As of this​ writing, 962 babies were born to parents using the new​ method, and 863 of them were girls. Use a 0.01 significance level to test the claim that the new method is effective in increasing the likelihood that a baby will be a girl. Identify the null​ hypothesis, alternative​ hypothesis, test​ statistic, P-value, conclusion about the null​ hypothesis, and final...
The following data was collected in a clinical trial evaluating a new compound designed to improve...
The following data was collected in a clinical trial evaluating a new compound designed to improve wound healing in trauma patients. The new compound is compared against a placebo. After treatment for 5 days with the new compound or placebo the extent of wound healing is measured and the data are shown below. Percent Wound Healing Treatment 0-25% 26-50% 51-75% 76-100% New Compound (n=125) 15 37 32 41 Placebo (n=125) 36 45 34 10 Is there a difference in the...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT